Overview

Companies

Metrics

Content

Purchase

Figure 1.1: CME Department Organization: Centralized vs. Decentralized
Figure 1.2: CME Departments’ Reporting Relationships
Figure 1.3: CME Staffing in FTEs by Company
Figure 1.4: Average Percentage of Dedicated Staff Time Given to Media Mix
Figure 1.5: CME Staffing Compared to Previous Year
Figure 1.6: CME Staffing Projections for Coming Year
Figure 1.7: Challenges to CME Program Management
Figure 1.8: Yearly CME Budgets at Surveyed Companies
Figure 1.9: Media Mix Spending: Budget Breakdown by Types of CME
Figure 1.10: CME Budgets Compared to Previous Year
Figure 1.11: CME Budget Projections for Coming Year

Figure 2.1: Breakdown of how Companies Align their CME Activities
Figure 2.2: Percent of CME Departments Receiving Input from Each Function
Figure 2.3: Top Challenges Faced by Participating Pharmaceutical CME Programs
Figure 2.4: Effectiveness of Companies’ CME Strategies
Figure 2.5: Percent of Companies CME Strategy
Figure 2.6: Percent of Companies Supporting CME by Continent

Figure 4.1: Number of CME Events Sponsored Compared to Last Year
Figure 4.2: Number of CME Events Supported by Surveyed Companies Annually
Figure 4.3: CME Spending Per Event at Surveyed Companies
Figure 4.4: Projections for Number of CME Events Sponsored in the Coming Year
Figure 4.5: Average Media Mix: Participation in Live vs. eCME Events
Figure 4.6: Media Mix As a Percentage of Company Budget
Figure 4.7: Media Mix as a Percentage of FTEs’ Dedicated Time
Figure 4.8: Top Challenges Faced by Participating Pharmaceutical CME Programs

Figure 5.1: CME Soft Goal Performance Measurement Process
Figure 5.2: Percentage of Drug Companies that Track CME Return on Investment (ROI)
Figure 5.3: Companies’ Self-Assessments of CME Events’ Return on Investment (ROI)

Figure 6.1: Top Challenges Faced by Participating Pharmaceutical Companies
Figure 6.2: US Sentencing Commission Guidelines